Literature DB >> 16844625

The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.

Feyzi Abacilar1, Omer Faruk Dogan, Umit Duman, Ibrahim Ucar, Metin Demircin, Unsal Ersoy, Riza Dogan, Erkmen Boke.   

Abstract

BACKGROUND: Systemic inflammatory response after cardiopulmonary bypass (CPB) is thought to result from contact of cellular and humoral blood components with the synthetic material of the extracorporeal circulation system, leukocyte and endothelial activation caused by ischemia and reperfusion or endotoxins, or by surgical trauma. Proinflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-8, play an important role in the inflammatory processes after CPB and may induce cardiac and lung dysfunction. This study examined the association of the increased release of TNF-alpha with increased myocardial and lung injury after CPB and its effect on postoperative morbidity.
METHODS: Twenty patients undergoing elective coronary artery bypass grafting (CABG) were included in the study. Four intervals of blood samples were obtaind and assayed for TNF-alpha, white blood cells, C-reactive protein, and erythrocyte sedimentation rate.
RESULTS: All patients were similar with regards to preoperative and intraoperative characteristics, and clinical outcomes were comparable. Plasma levels of TNF-alpha rose more than 20 pg/mL during and after standard CPB in 13 patients (group 1), whereas the plasma levels were less than 20 pg/mL in the remaining 7 patients (group 2) after CPB. The patients of the first group had increased mediastinal bleeding and prolonged intubation time compared to the other group.
CONCLUSION: Cardiac surgery and CPB stimulate systemic inflammatory processes characterized clinically by changes in cardiovascular and pulmonary function. Significant morbidity is rare, but most patients undergoing CPB exhibit some degree of organ dysfunction due to activation of the inflammatory response. This study showed that there were no major clinical results of TNF-alpha and white blood cell level, C-reactive protein, and erythrocyte sedimentation rate after the operation, but in patients with a high level of TNF-alpha (more than 20 pg/mL), increased mediastinal bleeding and longer orotracheal intubation time was observed. A number of studies have shown the increase of TNF-alpha after open heart surgery; however, the specific level of TNF-alpha was first described as 20 pg/mL in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844625     DOI: 10.1532/HSF98.20061012

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  5 in total

1.  Effects of topical hypothermia on postoperative inflammatory markers in patients undergoing coronary artery bypass surgery.

Authors:  Murat Kadan; Gokhan Erol; Bilgehan Savas Oz; Mehmet Arslan
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

2.  Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting.

Authors:  Cevdet Furat; Riza Dogan; Gokhan Ilhan; Ekrem Bayar; Berkan Ozpak; Hakan Kara; Şahin Bozok
Journal:  Cardiovasc J Afr       Date:  2016-11-10       Impact factor: 1.167

3.  Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient.

Authors:  Atefeh Fakharian; Saghar Barati; Monir Mohamadi; Farzaneh Dastan
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-01-08       Impact factor: 2.628

4.  Plasma from patients undergoing coronary artery bypass graft surgery does not activate endothelial cells under shear stress in vitro.

Authors:  Sophie F Ellermann; Thomas W L Scheeren; Rianne M Jongman; Katja Nordhoff; Christiane L Schnabel; Grietje Molema; Gregor Theilmeier; Matijs Van Meurs
Journal:  Int J Crit Illn Inj Sci       Date:  2021-09-25

5.  Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial.

Authors:  Ebrahim Shafiei; Mehrzad Bahtoei; Pema Raj; Afshin Ostovar; Daryoush Iranpour; Samad Akbarzadeh; Hooshang Shahryari; Abdorasoul Anvaripour; Rahim Tahmasebi; Thomas Netticadan; Ali Movahed
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.